INTRODUCTION
============

A growing financial crisis worldwide has caused an economic downturn in developing countries, thus causing people to work harder and have little time to take care themselves. This leads to increased risk of health problems ([@b17-jer-15-6-804]). Technology provides a quicker and easier way to live, but also gives less chance to participate in physical activities ([@b26-jer-15-6-804]). Furthermore, tobacco smoking is associated with multiple health problems and has become a public health concern ([@b8-jer-15-6-804]). Approximately 5 million of 2.3 billion smokers die globally each year from smoking. Mortality and morbidity from smoking are predicted mainly in developing countries ([@b8-jer-15-6-804]).

Adapting to life changes and alterations in a new society, participating with peer group activities, living outside the comfort of home, interconnecting with new friends and getting involved in the workforce are the causes of smoking in young adults ([@b30-jer-15-6-804]). Most smokers often smoke in the belief that it helps them to control their weight by increasing the metabolic rate, decreasing metabolic efficiency or reducing appetite, and ceasing to smoke causes weight gain ([@b3-jer-15-6-804]). Cigarette smokers in early adolescence find it difficult to stop smoking, due to physiological changes and symptoms from tobacco-related diseases clearly disappear. Young smokers are a vulnerable group that is unwilling to quit the habit ([@b3-jer-15-6-804]). As a consequence, education on smoking and how to control weight should target young adults ([@b35-jer-15-6-804]).

In noninvasive measurements of arterial stiffness (AS), cardio-ankle vascular index (CAVI) may detect early phases of atherosclerosis, and work as a predictor of AS, morbidity, and mortality from cardiovascular diseases (CVD) ([@b27-jer-15-6-804]). Although the prevalence of CVD is lower in young adults, it has been increasing in children and adolescents, who smoke and have less physical activity. Early detection of coronary artery disease (CAD) is important because vulnerable individuals such as asymptomatic young adults are more likely to experience cardiac events and later detection of subclinical coronary atherosclerosis ([@b31-jer-15-6-804]). The circulatory and respiratory systems help to accomplish daily routines efficiently ([@b9-jer-15-6-804]). Respiratory muscle plays an important role in the cardiorespiratory system. A decline of inspiratory muscle causes impairment of physical fitness and quality of life, especially with increased risk of CVD ([@b32-jer-15-6-804]). Therefore, providing knowledge and promoting good health in early years are important in avoiding health problems and improving adult quality of life ([@b7-jer-15-6-804]).

Many studies have demonstrated the association of a sedentary lifestyle and higher body mass index (BMI), overweight and obesity with a greater risk of CVD ([@b16-jer-15-6-804]; [@b36-jer-15-6-804]). Nevertheless, smokers of all ages, particularly in early adolescence or less than 30 years, smoke in the belief that it helps them to control their weight ([@b35-jer-15-6-804]). Few studies have demonstrated that physical inactivity and smoking in young adolescents with healthy weight has effect on AS, respiratory muscle strength and exercise performance. Therefore, this study aimed to determine the effect of smoking and physical activity on its parameters in physically active and inactive smokers and nonsmokers aged 20--30 years in order to improve understanding and promote the importance of exercise and smoking cessation.

MATERIALS AND METHODS
=====================

Subject enrollment
------------------

A total of 48 male participants were recruited into this study, which was carried out in accordance with the Declaration of Helsinki and approved by the Naresuan University Institutional Review Board (IRB No. 0132/62), at the Department of Physical Therapy, Naresuan University. The effect of sample size was determined based on a previous study ([@b28-jer-15-6-804]). The calculation was carried out with α=0.05 and 90% power. All of the participants were informed by the researchers about the aims, methods, and consequences of this study and they were free to decide whether to participate or not.

A cross-sectional study design with comparison of variables across four groups of participants was employed for this study. The 48 male participants, aged 20--30 years, were divided equally into four groups (n=12 in each group) based on the inclusion and exclusion criteria as follows: physically active male nonsmokers and smokers with normal BMI (18.5--22.9 kg/m^2^, n=12 per group), aged 20 to 30 years, who performed moderate or vigorous intensive exercise for more than 30 min, 5 days per week or more than 25 min, 3 days per week ([@b20-jer-15-6-804]); and physically inactive male nonsmokers and smokers with normal BMI (18.5--22.9 kg/m^2^, n=12 per group), who performed moderate or vigorous intensive exercise for less than 30 min, 5 days per week or less than 25 min, 3 days per week were enrolled into this study by using the International Physical Activity Questionnaire ([@b13-jer-15-6-804]). Smokers who had smoked on 25--30 days per month for at least 1 year, or nonsmokers who had not smoked before also were included in this study ([@b24-jer-15-6-804]).

The exclusion criteria were as follows: people with underlying comorbidity with cardiovascular, pulmonary and neurological diseases were excluded from this study. Subjects who had taken alcoholic beverages, caffeine or stimulation drugs for the central nervous system (CNS) within 48 hr prior to the tests, and those with musculoskeletal disease and could not follow the protocol also were excluded ([@b18-jer-15-6-804]). The demographic data of the participants (i.e., age, gender, occupation, and smoking) were collected from interviews by using the questionnaire.

Measurements of blood pressure and body composition
---------------------------------------------------

The volunteers were asked to abstain from taking alcoholic beverages, caffeine or CNS stimulating substances for at least 48 hr, and refrain from exercise for at least 24 hr before the tests. They should have had neither food nor water for at least 4 hr, and abstained form diuretics for at least 7 days, and they also were asked to empty their bladder at least 30 min before the tests ([@b22-jer-15-6-804]). All of the subjects had their blood pressure (BP) recorded in the sitting position by using a cuff BP machine (HEM-7130, Omron Healthcare Co. Ltd., Kyoto, Japan). Bioelectrical impedance analysis (HBF 375, Omron Healthcare Co. Ltd., Kyoto, Japan) was used to measure body composition (i.e., fat-free mass, body and visceral fat percentages) in a room with controlled temperature. Their hands and feet were cleaned before standing on a platform throughout the test with their arms raised and elbows extended straight out ([@b21-jer-15-6-804]).

Ankle-brachial index and CAVI measurement
-----------------------------------------

All of the participants were instructed not to smoke before testing or use stimulation drugs or substances related to the autonomic nervous and cardiovascular systems such as alcohol, caffeine and energy drinks ([@b27-jer-15-6-804]). The measurement was conducted during the morning in a temperature-controlled laboratory. Ankle-brachial index (ABI) and CAVI were assessed with a phonograph vascular screening appliance (VS-1500N, Fukuda Denshi Co. Ltd., Tokyo, Japan), and electrocardiogram (ECG) and arm and leg BP cuffs. All of the participants rested and laid down for measuring the leg and arm BP simultaneously throughout the test. The ABI and CAVI were calculated from pulse wave velocity through recording from the ECG and phonocardiogram. The nature and possible consequences of the procedure for CAVI measurement was performed by a qualified cardiothoracic technologist by following the manufacturer's instructions throughout the project ([@b27-jer-15-6-804]).

Respiratory muscle strength testing
-----------------------------------

The participants were familiarized with the instrument and procedure before the actual test. Maximal inspiratory pressure (MIP) and maximal expiratory pressure (MEP) were measured by an electronic pressure transducer (MicroRPM, Micromedical Ltd., Kent, UK) according to the American Thoracic Society/European Respiratory Society statement on respiratory muscle testing ([@b1-jer-15-6-804]). The MIP was assessed from residual volume, while the MEP started from total lung capacity, according to [@b2-jer-15-6-804]. The test was performed at least 3 times, and accomplished with a maximum of five maneuvers. The highest value among the measurements was chosen for analysis and compared with the reference value.

Maximum oxygen consumption test
-------------------------------

The pre-test criteria for exercise and vital signs were considered before the experimental procedure. ([@b29-jer-15-6-804]) The participants abstained from caffeine, chocolate, alcohol and nicotine intake for \>48 hr and also emptied their bladder completely within 30 min before the test. Maximum oxygen consumption (VO~2max~) was measured by cycle ergometer (Monark 828E, Monark Exercise AB, Vansbro, Sweden) by following the submaximal Astrand-Ryhming test protocol, and setting the rhythm at 50 repetitions per min. Active male participants performed initially at 1 Kilo Pond intensity (300--450 kpm/min) in order to maintain a heart rate (HR) of between 120 and 170 beats/min ([@b5-jer-15-6-804]). The HR for each stage was recorded for 6 min to determine a constant HR at the 56th min. VO~2max~ was calculated from their age factor and body weight to determined absolute (L/min) and relative VO~2max~ (mL/kg/min), respectively ([@b5-jer-15-6-804]).

Statistical analysis
--------------------

All of the data were analyzed using SPSS ver. 17.0 (SPSS Inc., Chicago, IL, USA). The data normality was analyzed by the Shapiro--Wilk test. Comparisons among groups were conducted using the two-way analysis of variance design, which was used to test the main effects of physical activity in the groups (smokers vs. nonsmokers) and the interaction effect of physical activity between the groups.

RESULTS
=======

Physical characteristics of the participants
--------------------------------------------

[Table 1](#t1-jer-15-6-804){ref-type="table"} shows the demographic characteristics of the participants in the active and inactive smoking groups (n=12 in each group), and the active and inactive nonsmoking groups (n=12 in each group). The age, height, HR, systolic and diastolic BP were not statistically significant among the groups (*P*\>0.05). Results showed that the BMI and weight in smokers were lower than in the nonsmokers group (*F*=6.65, *P*=0.013, *F*=5.46, *P*=0.024, respectively). The current smoking duration and frequency were higher in smokers than in nonsmokers (*F*=128.57, *P*\<0.001, *F*=295.95, *P*\<0.001, respectively). The data showed no effects of significant interaction on any demographic data (*P*\>0.05).

Body composition, respiratory muscle strength, and aerobic capacity
-------------------------------------------------------------------

Data of body composition, respiratory muscle strength, and aerobic capacity are summarized in [Table 2](#t2-jer-15-6-804){ref-type="table"}. Body and visceral fat percentage were significantly different. Body fat and visceral fat percentages were significantly higher in physically inactive than in physically active males (*F*=28.87, *P*=0.001, *F*=6.99, *P*=0.011, respectively) and in smokers compared to nonsmokers (*F*=22.46, *P*=0.001, *F*=5.51, *P*=0.024,). The main effect of smoking showed no significant difference in fat-free mass (*F*=0.051, *P*=0.822), but the main effects of physical inactivity exhibited a significant difference. Fat-free mass was significantly higher in physically active than in physically inactive males (*F*=8.01, *P*=0.007).

In addition, the results showed a significant difference in the interaction of body fat percentage (*F*=6.835, *P*=0.012), but not in the interaction of fat-free mass (*F*=0.356, *P*=0.554) or visceral fat (*F*=0.597, *P*=0.444). Physical activity and smoking showed a significant main effect, with VO~2max~, MIP and MEP in the physically active group being significantly higher than in the inactive group (*F*=21.929, *P*=0.001, *F*=5.577, *P*=0.023, *F*=4.993, *P*= 0.031) and also in the smoking group compared with the nonsmoker group (*F*=7.975, *P*=0.007, *F*=6.012, *P*=0.018, *F*=5.291, *P*=0.026). There were no effects of interaction between physical inactivity and smoking on VO~2max~ (*F*=1.435, *P*=0.237), MIP or MEP (*F*=0.386, *P*=0.537, *F*=0.588, *P*=0.447, respectively) ([Table 3](#t3-jer-15-6-804){ref-type="table"}).

CAVI and ABI
------------

Data on the CAVI and ABI are shown in [Table 4](#t4-jer-15-6-804){ref-type="table"}. Mean CAVI was significantly higher in the physically inactive (*F*=21.375, *P*= 0.001) and smoking group (*F*=20.320, *P*=0.001), whereas, ABI was not observed as significantly different in smokers (*F*=0.256, *P*=0.695) or the physically inactive group (*F*=0.409, *P*=0.526). There were no effects of interaction between physical activity and smoking on ABI (*F*=0.693, *P*=0.410), but an interaction effect of mean CAVI was found (*F*=5.718, *P*=0.021). In similarity, the right and left sides of the CAVI were significantly higher in the physically inactive (*F*=30.38, *P*=0.001, *F*=30.98, *P*=0.001) and smoking group (*F*=33.722, *P*=0.001, *F*=37.849, *P*=0.001), but a significant difference in the right and left side of ABI values was not observed in smokers (*F*=0.298, *P*=0.693, *F*=0.333, *P*=0.567) or the physically inactive group (*F*=0.337, *P*=0.565, *F*=0.543, *P*=0.465). The result showed interaction on the right and left sides of the CAVI (*F*=5.580, *P*=0.023, *F*=5.493, *P*=0.024), but did not find interaction on both sides of the ABI (*F*=0.243, *P*=0.596, *F*=0.341, *P*=0.546, respectively).

DISCUSSION
==========

The findings from this study demonstrate that smoking and physically inactive participants exhibited an imbalance of body composition through increased body fat, visceral fat percentage and increased AS by increased CAVI, while ABI was not significantly different among the groups. Fat-free mass in physically inactive participants was lower than in the physically active group. Respiratory muscle and VO~2max~ were diminished by smoking and physical inactivity. This study also found the effects of interaction between physical inactivity and smoking on body fat and CAVI.

CAVI has been a noninvasive approach to the assessment of AS and predictor risk of CVD in high-risk patients ([@b27-jer-15-6-804]). This study found that CAVI in all of the participants was at a healthy level, with a cutoff point of less than 9%, and an increase of CAVI in smokers associated with AS ([@b10-jer-15-6-804]). These results are consistent with a previous study by [@b15-jer-15-6-804]. that showed peripheral arterial function declining in young moderate smokers. The atherosclerotic process in younger adults, however, may progress without any major symptoms or can even be asymptomatic ([@b31-jer-15-6-804]). Harmful substance in tobacco contributes to decreased arterial elasticity, and smoking causes increased risk of AS associated with increased BP in smokers ([@b15-jer-15-6-804]).

Furthermore, inactive participants conversely increased the risk of AS by increasing CAVI, suggesting that physical inactivity is a risk factor in increasing AS in early adulthood ([@b10-jer-15-6-804]). To the authors' knowledge, a significant difference was shown in the effects of interaction between BF percentage and the CAVI. The result suggested that accommodating fat could be considered a risk factor for vascular problems ([@b23-jer-15-6-804]). This study did not find a significant difference of ABI in smokers and physically inactive people. The unchanged ABI was due to studying younger healthy individuals, without underlying diseases, but it may not be relevant to a clinical study. This effect would be under represented by changes in the ABI ([@b34-jer-15-6-804]).

Physical fitness is considered as a marker of health and physical performance in daily life ([@b6-jer-15-6-804]). This study found that VO~2max~ decreased in smokers and the physically inactive group, as function of the respiratory muscles plays an important role in pulmonary ventilation. Inspiratory muscle strength that decreased in the physically inactive and smoking participants was associated with increased visceral fat. Previous study demonstrated that excess fat tissue on the thorax, which causes mechanical disadvantage, decreased diaphragmatic movement, and increased respiratory workload and ineffective biomechanics to the consequent respiratory muscle ([@b4-jer-15-6-804]; [@b14-jer-15-6-804]). This study was conducted in physically inactive participants and smokers with normal weight, but higher body and visceral fat mass, who exhibited inspiratory muscle decline, which suggested that participants of normal weight, but accommodating fat from smoking and physically inactive behavior, are at risk of respiratory muscle impairment ([@b25-jer-15-6-804]). Physical inactivity is as harmful as smoking on body composition, and exercise performance ([@b11-jer-15-6-804]).

Shift in environment, participating with new friends and society causes younger adults to try smoking and they can progress to chronic smokers in the future, especially when some of them believe that smoking helps to control their weight ([@b30-jer-15-6-804]; [@b3-jer-15-6-804]). This study also showed that smoking had major effects on BMI and weight, as smokers had lower weight and BMI than nonsmokers. Even though participants with normal weight performed appropriate exercise, smoking exerted an imbalance in body composition by increasing fat mass and declining exercise performance, with increased risk of CVD ([@b12-jer-15-6-804]). Good vascular health improves working capacity and plays an important role in the prevention of CVD ([@b19-jer-15-6-804]). This study represents the overall routine of physical testing, cardiovascular checking is essential in health promotion of physical performance in younger adults ([@b33-jer-15-6-804]), persuading them to perceive their health through stopping tobacco smoking and controlling body fat by appropriate exercise rather than controlling their weight by smoking.

There are some limitations in this study. The small sample size could have affected the interaction outcomes. It is therefore suggested that further studies with larger sample sizes be conducted, using a prospective cohort study. This study did not explain the pathophysiological mechanisms of smoking or AS. Further study is needed to explain these mechanisms.

In summary, the results of this study suggest that healthy normal weight participants who not only exercise, but also smoke, can be at risk of CAD, respiratory and physical fitness decline. This study highlights the importance of appropriate physical activity and cigarette cessation in younger adults before they become addicted and adopt smoking in order to control their weight.
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###### 

General characteristics of the participants

  Parameter                                     Active nonsmokers   Inactive nonsmokers   Active smokers   Inactive smokers   *P*-value             
  --------------------------------------------- ------------------- --------------------- ---------------- ------------------ ----------- --------- -------
  Age (yr)                                      24.42±4.03          25.08±4.01            25.67±4.05       24.25±4.20         0.186       0.812     0.443
                                                                                                                                                    
  Height (cm)                                   170.86±5.06         169.92±5.40           171.42±5.70      168.83±5.49        0.264       0.863     0.606
                                                                                                                                                    
  Weight (kg)                                   64.69±4.31          64.05±4.80            62.44±4.32       61.12±4.60         0.558       0.024     0.713
                                                                                                                                                    
  BMI (kg/m^2^)                                 22.13±0.65          22.15±0.72            21.27±1.50       21.43±1.15         0.775       0.013     0.814
                                                                                                                                                    
  HR (BPM)                                      69.83±6.04          73.83±7.57            71.75±6.32       73.25±6.58         0.159       0.730     0.519
                                                                                                                                                    
  SBP (mmHg)                                    106.92±9.87         108.08±8.86           105.92±7.80      106.42±9.66        0.752       0.614     0.899
                                                                                                                                                    
  DBP (mmHg)                                    68.58±6.20          69.92±4.68            69.25±4.20       70.08±5.47         0.417       0.594     0.933
                                                                                                                                                    
  Smoking measures                                                                                                                                  
   Smoking duration (yr)                        0.00±0.00           0.00±0.00             8.33±3.82        7.92±3.45          0.727       \<0.001   0.727
   Current smoking frequency (cigarettes/day)   0.00±0.00           0.00±0.00             11.87±3.56       12.13±3.83         0.764       \<0.001   0.764
                                                                                                                                                    
  Physical activity                                                                                                                                 
   Moderate                                     7 (58.33)           7 (58.33)             6 (50.00)        8 (66.67)                                
   Vigorous                                     5 (41.67)           5 (41.67)             6 (50.00)        4 (33.33)                                

Values are presented as mean±standard deviation or number (%).

BMI, body mass index; HR, heart rate; BPM, beats per min; SBP, systolic blood pressure; DBP, diastolic blood pressure; mmHg, millimeter of mercury.

###### 

The result for body composition

  Parameter   Active nonsmokers   Inactive nonsmokers   Active smokers   Inactive smokers   *P*-value           
  ----------- ------------------- --------------------- ---------------- ------------------ ----------- ------- -------
  TBF (%)     14.95±3.23          17.49±3.06            16.34±3.42       24.27±3.26         0.001       0.001   0.012
  VF (%)      4.74±2.60           7.14±2.20             6.19±3.53        9.47±3.06          0.011       0.024   0.444
  FFM (%)     34.33±3.89          32.02±3.48            34.71±3.35       30.17±3.51         0.007       0.822   0.554

Values are presented as mean±standard deviation.

TBF, total body fat; VF, visceral fat; FFM, fat-free mass.

###### 

The result for respiratory muscle strength and aerobic capacity

  Parameter              Active nonsmokers   Inactive nonsmokers   Active smokers   Inactive smokers   *P*-value           
  ---------------------- ------------------- --------------------- ---------------- ------------------ ----------- ------- -------
  MIP                    101.42±14.48        90.42±12.21           90.08±12.27      83.67±11.98        0.023       0.018   0.537
  MEP                    108.08±12.87        95.66±10.81           96.41±16.38      90.83±12.02        0.031       0.026   0.447
  VO~2max~ (mL/kg/min)   51.48±9.03          43.33±7.39            47.67±9.38       33.92±6.87         0.001       0.007   0.237

Values are presented as mean±standard deviation.

MIP, maximal inspiratory pressure; MEP, maximal expiratory pressure; VO~2max~; maximal oxygen consumption.

###### 

The result for cardio-ankle vascular index (CAVI) and ankle-brachial index (ABI)

  Parameter   Active nonsmokers   Inactive nonsmokers   Active smokers   Inactive smokers   *P*-value           
  ----------- ------------------- --------------------- ---------------- ------------------ ----------- ------- -------
  CAVI                                                                                                          
   Right      6.57±0.26           6.83±0.29             6.71±0.37        7.53±0.22          0.001       0.001   0.023
   Left       6.55±0.25           6.82±0.27             6.72±0.36        7.55±0.25          0.001       0.001   0.024
   Mean       6.56±0.25           6.82±0.28             6.72±0.37        7.53±0.23          0.001       0.001   0.021
                                                                                                                
  ABI                                                                                                           
   Right      1.01±0.07           1.04±0.10             1.02±0.07        1.01±0.08          0.565       0.693   0.596
   Left       1.01±0.08           1.04±0.10             1.01±0.08        1.01±0.08          0.465       0.567   0.546
   Mean       1.01±0.08           1.04±0.11             1.02±0.08        1.01±0.08          0.526       0.695   0.410

Values are presented as mean±standard deviation.
